Skip to content
akaturk Academic measurement

Article detail · 2018

A five-year, single-centre experience on ultrasound-assisted, catheter-directed thrombolysis in patients with pulmonary embolism at high risk and intermediate to high risk

EuroIntervention

YÖKSİS OpenAlex SJR Q1 JCR Q2 Citations 32 Top 10% Percentile 91.1% FWCI 2.68
Year
2018
ISSN
1774-024X
Type
article

Data source split

  • YÖKSİS YÖKSİS article record
  • OpenAlex OpenAlex enrichment (abstract, citations, topics)

Abstract

English (OpenAlex)

AIMS: In this single-centre study, we aimed to evaluate the short- and long-term efficacy and safety outcomes of ultrasound-assisted thrombolysis (USAT) performed in patients with acute pulmonary embolism (PE) at intermediate to high risk and high risk (IHR, HR). METHODS AND RESULTS: The study group comprised 141 retrospectively evaluated patients with PE who underwent USAT. Tissue-type plasminogen activator (t-PA) dosage was 36.1±15.3 mg, and infusion duration was 24.5±8.1 hours. USAT was associated with improvements in echocardiographic measures of right ventricle systolic function, pulmonary arterial (PA) obstruction score, right to left ventricle diameter ratio (RV/LV), right to left atrial diameter ratio and PA pressures, irrespective of the risk (p<0.0001 for all). In-hospital mortality, major and minor bleeding rates were 5.7%, 7.8% and 11.3%, respectively. Follow-up data (median 752 days) were available in all patients. Absolute and % changes in RV/LV and % changes in PA mean pressure were significantly higher in patients younger than 65 years compared with older patients, whereas bleeding, 30-day and long-term mortality were not related to age, t-PA dosage or infusion duration. HR versus IHR increased 30-day mortality. CONCLUSIONS: USAT was associated with improvements in thrombolysis and stabilisation of haemodynamics along with relatively low rates of complications in patients with PE, regardless of the risk status. However, HR still confers a higher short-term mortality. Increasing the t-PA dosage and prolongation of infusion may not offer benefit in USAT treatments.

Topics

  • Venous Thromboembolism Diagnosis and Management
  • Atrial Fibrillation Management and Outcomes
  • Ultrasound in Clinical Applications

Primary topic Venous Thromboembolism Diagnosis and Management

Authors

  1. CİHANGİR KAYMAZ
  2. ÖZGÜR YAŞAR AKBAL
  3. AYKUN HAKGÖR İSTANBUL MEDİPOL ÜNİVERSİTESİ
  4. HACER CEREN TOKGÖZ
  5. ALİ KARAGÖZ İSTANBUL ÜNİVERSİTESİ
  6. İBRAHİM HALİL TANBOĞA
  7. SEDA TANYERİ
  8. BERHAN KESKİN
  9. SEVİM TÜRKDAY
  10. DURMUŞ DEMİR
  11. CEM DOĞAN
  12. ZÜBEYDE BAYRAM
  13. REZZAN DENİZ ACAR
  14. BÜŞRA GÜVENDİ
  15. NİHAL ÖZDEMİR
  16. VICTOR F TAPSON
  17. STAVROS KONSTANTINIDES